CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleLevered free cash flow is $26.06M, above the global median of $18.73M
- PositionDebt-to-equity is 0×, lower than 95% of its Medical Devices peers (median 0.11×)
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.14%Below 5Y avg (0.72%)
Annual Rate
CNY 0.03Paid annual
Payout Ratio
65.0%Moderate
Last Ex-Dividend
Sep 22, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.63BCNY393.18M · vs all stocks (USD)
Trailing P/E
108.70xvs Medical Devices peers
Revenue (TTM)
359.10MCNY53.58M · vs all stocks (USD)
Profit Margin
6.49%vs Medical Devices peers
Beta
1.16xvs all stocks
52-Week Change
-41.26%vs all stocks
Market Capitalization
2.63BCNY393.18M · vs all stocks (USD)
Enterprise Value
2.32BCNY345.58M · vs all stocks (USD)
Trailing P/E
108.70xvs Medical Devices peers
Price to Sales (TTM)
7.34xvs Medical Devices peers
Price to Book (MRQ)
3.30xvs Medical Devices peers
Enterprise to Revenue
6.45xvs Medical Devices peers
Enterprise to EBITDA
77.27xvs Medical Devices peers
Gross Margin
48.07%vs Medical Devices peers
Profit Margin
6.49%vs Medical Devices peers
Operating Margin
13.49%vs Medical Devices peers
Return on Assets (TTM)
0.92%vs Medical Devices peers
Return on Equity (TTM)
2.91%vs Medical Devices peers
Revenue (TTM)
359.10MCNY53.58M · vs all stocks (USD)
Revenue per Share (TTM)
3.09CNYUpdated Sep 21, 2026Quarterly Revenue Growth
20.80%vs Medical Devices peers
Gross Profit (TTM)
154.83MCNY23.10M · vs all stocks (USD)
EBITDA (TTM)
35.60MCNY5.31M · vs all stocks (USD)
Net Income (TTM)
23.32MCNY3.48M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
55.10%vs Medical Devices peers
Operating Cash Flow (TTM)
65.70MCNY9.80M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
174.63MCNY26.06M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0300CNYUpdated Sep 21, 2026Trailing Annual Dividend Yield
0.14%vs all stocks
5-Year Average Dividend Yield
0.72%vs all stocks
Payout Ratio
65.00%vs Medical Devices peers
Revenue
339.54MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
185.25MCNYFY2025 · Dec 31, 2025Gross Profit
154.29MCNYFY2025 · Dec 31, 2025Operating Income
13.70MCNY2.04M · vs all stocks (USD)
Pre-tax Income
16.74MCNYFY2025 · Dec 31, 2025Income Tax Expense
452.64KCNYFY2025 · Dec 31, 2025Net Income
16.29MCNYFY2025 · Dec 31, 2025EBIT
13.70MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
35.60MCNYFY2025 · Dec 31, 2025Research & Development
57.21MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
26.00MCNYFY2025 · Dec 31, 2025Other Operating Expenses
5.34MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
4.93MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
14.78MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.1400CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.1400CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
117.75MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
117.75MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
16.29MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
199.37KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
29.88MCNYFY2025 · Dec 31, 2025Free Cash Flow
-17.01MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
78.55MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
16.29MCNYFY2025 · Dec 31, 2025Other Non-cash Items
1.89MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-1.23MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
12.93MCNYFY2025 · Dec 31, 2025Capital Expenditures
-46.89MCNYFY2025 · Dec 31, 2025Purchase of Investments
-2.00MCNYFY2025 · Dec 31, 2025Sale of Investments
9.38MCNYFY2025 · Dec 31, 2025Other Investing Activity
41.90MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
2.40MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-3.67MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-24.24MCNYFY2025 · Dec 31, 2025Other Financing Charges
-12.34MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-40.25MCNYFY2025 · Dec 31, 2025Shares Outstanding
121.20MSharesUpdated Sep 21, 2026Float Shares
45.56MSharesUpdated Sep 21, 2026% Held by Insiders
62.35%vs all stocks
% Held by Institutions
2.29%vs all stocks
Total Cash (MRQ)
292.49MCNY43.65M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.44CNYUpdated Sep 21, 2026Total Debt (MRQ)
0.00CNYvs all stocks (USD)
Total Debt to Equity (MRQ)
0.00xvs Medical Devices peers
Current Ratio (MRQ)
3.61xvs Medical Devices peers
Book Value per Share (MRQ)
6.59CNYUpdated Sep 21, 2026Total Assets
958.97MCNY143.10M · vs all stocks (USD)
Total Current Assets
549.85MCNYFY2025 · Dec 31, 2025Total Liabilities
154.68MCNYFY2025 · Dec 31, 2025Total Non-current Assets
409.12MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
2.55MCNYFY2025 · Dec 31, 2025Total Current Liabilities
152.14MCNYFY2025 · Dec 31, 2025Cash
148.57MCNYFY2025 · Dec 31, 2025Cash Equivalents
519.76KCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
149.09MCNYFY2025 · Dec 31, 2025Other Short-term Investments
61.12MCNYFY2025 · Dec 31, 2025Accounts Receivable
55.07MCNYFY2025 · Dec 31, 2025Inventory
126.54MCNYFY2025 · Dec 31, 2025Accounts Payable
15.86MCNYFY2025 · Dec 31, 2025Other Current Liabilities
6.54MCNYFY2025 · Dec 31, 2025Common Stock (Book)
121.20MCNYFY2025 · Dec 31, 2025Retained Earnings
242.96MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
804.29MCNY120.02M · vs all stocks (USD)
52-Week Low
16.38CNYUpdated Sep 21, 202652-Week High
38.00CNYUpdated Sep 21, 202652-Week Change
-41.26%vs all stocks
Beta
1.16xvs all stocks
50-Day MA
20.03CNYUpdated Sep 21, 2026200-Day MA
23.59CNYUpdated Sep 21, 2026Avg 10-Day Volume
2.72MSharesUpdated Sep 21, 2026Avg 30-Day Volume
3.06MSharesUpdated Sep 21, 2026Diluted EPS (TTM)
0.2000CNYUpdated Sep 21, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Debt-to-equity is 0×, lower than 95% of its Medical Devices peers (median 0.11×)Notable
Debt-to-equity: 0.00Industry median: 0.11Industry P5: 0.00Peers compared: 102
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.48Profit Margin: 0.06
Financial Health
Altman Z-Score 11.47: safe zoneNotable
Altman Z-Score: 11.47
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Levered free cash flow is $26.06M, above the global median of $18.73MNotable
Levered free cash flow (USD): 26,057,966.285Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Zura Bio Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Opus Genetics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Editas Medicine Inc.
Tier 1ProductionApproval-Gated PipelineRule
Shenzhen Bioeasy Biotechnology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Kontour Xi'an Medical Technology Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Allergy Therapeutics plc
Tier 1ProductionApproval-Gated PipelineRule
Foresee Pharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
G2GBio Inc.
Tier 1ProductionApproval-Gated PipelineRule
Ars Pharmaceuticals Inc
Tier 1ProductionApproval-Gated PipelineRule
Orthofix Medical Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Hafnia Limited
1 interpretationMinimal Tax and Interest Drag
Heilongjiang Publishing & Media Co. Ltd.
1 interpretationMinimal Tax and Interest Drag
Strait Innovation Internet Co., Ltd.
1 interpretationMinimal Tax and Interest Drag